Mark S. Fradin

790 citations
10 papers · 578 indexed · h-index 8
Topics
Psoriasis: Treatment and Pathogenesis (5 papers)Autoimmune Bullous Skin Diseases (4 papers)Dermatology and Skin Diseases (3 papers)
Partner nations
United StatesSwitzerland

In The Last Decade

Mark S. Fradin

10 papers receiving 541 citations

Peers

Mark S. Fradin
Comparison fields: 5 of 60
  • Immunology 306
  • Dermatology 178
  • Pathology and Forensic Medicine 162
  • Rheumatology 131
  • Molecular Biology 72
Replace Caleb Hwang with:
Caleb Hwang Taiwan
Alexander Marsland United Kingdom
Ramazan Güneşaçar Türkiye
SE Marshall United Kingdom
Cláudia Giuli Santi Brazil
Ada Lo Schiavo Italy
E. Prati Italy
Jatin Patel United Kingdom
C. W. Steiner Austria
S A Bell Germany
Mark S. Fradin relative to Caleb Hwang Taiwan Caleb Hwang's profile →
Citations per field
00.5×
Caleb Hwang · 1×
Citations per year

Countries citing papers authored by Mark S. Fradin

Since Specialization
Citations

This map shows the geographic impact of Mark S. Fradin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Fradin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Fradin more than expected).

Fields of papers citing papers by Mark S. Fradin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Fradin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Fradin. The network helps show where Mark S. Fradin may publish in the future.

Co-authorship network of co-authors of Mark S. Fradin

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Fradin. A scholar is included among the top collaborators of Mark S. Fradin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Fradin. Mark S. Fradin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 1
2 15
3 62
4 71
5 325
6 20
7 5
8 18
9 50
10 11

About Mark S. Fradin

Mark S. Fradin is a scholar working on Dermatology, Immunology and Pathology and Forensic Medicine, having authored 10 papers that have together received 578 indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (5 papers), Autoimmune Bullous Skin Diseases (4 papers) and Dermatology and Skin Diseases (3 papers). The work is most often cited by research in Dermatology (178 citations), Immunology (306 citations) and Transplantation (36 citations). Mark S. Fradin has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Charles N. Ellis, John J. Voorhees, John J. Voorhees, Joseph M. Messana, A. Howland Hartley, Eric J. Duell, Thomas M Annesley, Kevin D. Cooper, Suzanne M. Wheeler and Leslie L. Rocher. Their work appears in journals such as New England Journal of Medicine, Kidney International and Journal of the American Academy of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026